C-reactive protein/albumin ratio is a prognostic indicator for predicting surgical intervention and mortality in neonates with necrotizing enterocolitis
Pediatric Surgery International · 2021-07 · 37 (7) · 881-886
DOI: 10.1007/s00383-021-04879-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Surgery International, online erschienen am 29.03.2021. Verfasst von Amir T Mohd Amin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Surgery, The Royal London Hospital, London, UK. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Johann Wolfgang Goethe-Universität, Frankfurt am Main.
Abstract (Originalsprache)
Purpose
The role of hypoalbuminemia and raised C-reactive protein (CRP) levels in predicting critical prognosis has been described extensively in adult literature. However, there are limited studies in pediatrics, particularly neonates. The CRP/albumin (CRP/ALB) ratio is often associated with higher mortality, organ failure and prolonged hospital stay. We hypothesized that the serum CRP/ALB ratio has a prognostic value in predicting surgery and mortality in neonates with necrotizing enterocolitis (NEC).
Methods
Retrospective review of all neonates with clinical and radiological evidence of non-perforated NEC that were treated in a tertiary-level referral hospital between 2009 and 2018. General patient demographics, laboratory parameters and outcomes were recorded. Receiver operating characteristics analysis was performed to evaluated optimal cut-offs and area under the curve (AUC) with 95% confidence intervals (CI).
Results
A total of 191 neonates were identified. Of these, 103 (53.9%) were born at ≤ 28 weeks of gestation and 101 (52.9%) had a birth weight of ≤ 1000 g. Eighty-four (44.0%) patients underwent surgical intervention for NEC. The overall survival rate was 161/191 (84.3%). A CRP/ALB ratio of ≥ 3 on day 2 of NEC diagnosis was associated with a statistically significant higher likelihood for surgery [AUC 0.71 (95% CI 0.63–0.79); p < 0.0001] and mortality [AUC 0.66 (95% CI 0.54–0.77); p = 0.0150], respectively.
Conclusions
A CRP/ALB ratio of ≥ 3 on day 2 is indicative of a critical pathway in neonates with radiologically confirmed, non-perforated NEC. This could be used as an additional criterion to guide parental counselling in NEC for surgical intervention and mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Surgery, The Royal London Hospital, London, UK.
- Centre for Epidemiology and Evidence Based Practice, Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
- Department of Pediatric Surgery, The Royal London Hospital, London, UK. Florian.Friedmacher@nhs.net.
- Department of Pediatric Surgery, University Hospital Frankfurt, Goethe University Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt, Germany. Florian.Friedmacher@nhs.net.
Förderung
- Johann Wolfgang Goethe-Universität, Frankfurt am Main
Zitieren
APA
Mohd Amin, A. T., Zaki, R. A., Friedmacher, F., & Sharif, S. P. (2021). C-reactive protein/albumin ratio is a prognostic indicator for predicting surgical intervention and mortality in neonates with necrotizing enterocolitis. Pediatric Surgery International, 37(7), 881-886. https://doi.org/10.1007/s00383-021-04879-1
Vancouver
Mohd Amin AT, Zaki RA, Friedmacher F, Sharif SP. C-reactive protein/albumin ratio is a prognostic indicator for predicting surgical intervention and mortality in neonates with necrotizing enterocolitis. Pediatric Surgery International. 2021;37(7):881-886. doi:10.1007/s00383-021-04879-1
BibTeX
@article{MohdAmin2021,
author = {Mohd Amin, Amir T and Zaki, Rafdzah A and Friedmacher, Florian and Sharif, Shazia P},
title = {C-reactive protein/albumin ratio is a prognostic indicator for predicting surgical intervention and mortality in neonates with necrotizing enterocolitis},
journal = {Pediatric Surgery International},
year = {2021},
volume = {37},
number = {7},
pages = {881--886},
doi = {10.1007/s00383-021-04879-1}
}
EUVIMED